[HTML][HTML] An aggrephagy-related LncRNA signature for the prognosis of pancreatic adenocarcinoma
X Huang, H Chi, S Gou, X Guo, L Li, G Peng, J Zhang… - Genes, 2023 - mdpi.com
Pancreatic adenocarcinoma (PAAD) is a common, highly malignant, and aggressive
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
X Huang, H Chi, S Gou, X Guo, L Li, G Peng… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Pancreatic adenocarcinoma (PAAD) is a common, highly malignant, and aggressive
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma.
X Huang, H Chi, S Gou, X Guo, L Li, G Peng, J Zhang… - Genes, 2023 - europepmc.org
Pancreatic adenocarcinoma (PAAD) is a common, highly malignant, and aggressive
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
X Huang, H Chi, S Gou, X Guo, L Li, G Peng, J Zhang… - Genes, 2023 - agris.fao.org
Pancreatic adenocarcinoma (PAAD) is a common, highly malignant, and aggressive
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
X Huang, H Chi, S Gou, X Guo, L Li, G Peng, J Zhang… - Genes, 2023 - search.proquest.com
Pancreatic adenocarcinoma (PAAD) is a common, highly malignant, and aggressive
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
[HTML][HTML] An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
X Huang, H Chi, S Gou, X Guo, L Li, G Peng, J Zhang… - Genes, 2023 - ncbi.nlm.nih.gov
Pancreatic adenocarcinoma (PAAD) is a common, highly malignant, and aggressive
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma.
X Huang, H Chi, S Gou, X Guo, L Li, G Peng… - …, 2023 - search.ebscohost.com
Pancreatic adenocarcinoma (PAAD) is a common, highly malignant, and aggressive
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …
gastrointestinal tumor. The conventional treatment of PAAD shows poor results, and patients …